Accession Number: | 0001209191-20-037909 |
Date: | 2020-06-17 |
Issuer: | ORCHARD THERAPEUTICS PLC (ORTX) |
Original Submission Date: |
DUNOYER MARC
C/O ORCHARD THERAPEUTICS PLC
108 CANNON STREET
LONDON, X0 EC4N 6EU
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 7.81 | 2020-06-17 | deemed execution date | A | 35,000 (a) | 2030-06-16 | ordinary shares 35,000 | $7.81 | 35,000 | direct |
ID | footnote |
---|---|
f1 | all of the shares subject to this option vest upon the earlier to occur of june 17, 2021 or the date of the 2021 annual general meeting of the company. |
f2 | the ordinary shares may be represented by american depositary shares, each of which currently represents one ordinary share. |